ReviewGene-to-screenPharmacogenomics of the cytochrome P450 2C family: impacts of amino acid variations on drug metabolism

- The interindividual variability of CYP2C members and its impact in drug metabolism are reviewed.
- Current advances in molecular modeling of CYP2C polymorphisms are summarized.
- Structural bases of amino acid variants of CYP2C members affecting drug metabolism are discussed.

Pharmacogenomics investigates DNA and RNA variations in the human genome related to drug responses. Cytochrome P450 (CYP) is a supergene family of drug-metabolizing enzymes responsible for the metabolism of approximately 90% of human drugs. Among the major CYP isoforms, the CYP2C subfamily is of clinical significance because it metabolizes approximately 20% of clinically administrated drugs and represents several variant alleles leading to adverse drug reactions or altering drug efficacy. Here, we review recent progress on understanding the interindividual variability of the CYP2C members and the functional and clinical impact on drug metabolism. We summarize current advances in the molecular modeling of CYP2C polymorphisms and discuss the structural bases and molecular mechanisms of amino acid variants of CYP2C members that affect drug metabolism.